In This Article:
Acadia Healthcare Company, Inc. ACHC is set to report first-quarter 2025 results on May 12, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is pegged at 42 cents per share on revenues of $770.5 million.
First-quarter earnings estimates declined 8 cents per share in the past 60 days. The bottom-line estimate indicates a year-over-year decrease of 50%. However, the Zacks Consensus Estimate for the Behavioral healthcare service provider's quarterly revenues implies year-over-year growth of 0.3%. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
Image Source: Zacks Investment Research
For 2025, the Zacks Consensus Estimate for Acadia Healthcare’s revenues is pegged at $3.33 billion, implying a year-over-year rise of 5.7%. But the consensus mark for current-year EPS is pegged at $2.76, implying a fall of 16.4% on a year-over-year basis.
Acadia Healthcare beat the consensus estimate for earnings in three of the last four quarters and missed once, the average surprise being negative 0.4%. This is depicted in the figure below.
Acadia Healthcare Company, Inc. Price and EPS Surprise
Acadia Healthcare Company, Inc. price-eps-surprise | Acadia Healthcare Company, Inc. Quote
Q1 Earnings Whispers for ACHC
Our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat, but that is not the case here.
ACHC has an Earnings ESP of 0.00% and a Zacks Rank #4 (Sell) at present. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
What is Shaping ACHC’s Q1 Results?
The Zacks Consensus Estimate and our model estimate for revenue per patient day imply a 2% year-over-year rise. Also, both the consensus estimate and our model estimate for Residential Treatment Centers’ revenues indicate a 9.7% jump from the year-ago level of $85.6 million.
Both estimates for U.S. same-facility admissions indicate a marginal increase from a year ago. Similarly, both the Zacks Consensus Estimate and our model estimate for Specialty Treatment Facilities’ revenues signal a 0.1% increase from the year-ago figure of $143.8 million.
While the above-mentioned factors are likely to have supported Acadia Healthcare’s first-quarter revenues, rising expenses are likely to have affected its profit levels, making an earnings beat uncertain. We expect total expenses to have increased more than 11% in the to-be-reported quarter due to higher salaries, wages and benefits, professional fees and other operating costs. Also, with rising utilization, supply costs are expected to have increased in the first quarter.